* The opioid antagonist naloxegol (Movantik) is now approved to treat opioid-induced constipation in adults with chronic noncancer pain.
* The most common adverse effects are abdominal pain, diarrhea, nausea, flatulence, vomiting, and headache.
Un proyecto de la Biblioteca de la Universidad Complutense de Madrid